We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Distributors Join Fight Against Aggrenox Pay-for-Delay Deal
Distributors Join Fight Against Aggrenox Pay-for-Delay Deal
Drug distributors are suing Barr Pharmaceuticals and Boehringer Ingelheim (BI), alleging in a class-action complaint that the drugmakers crafted a $120 million pay-for-delay deal to keep a generic version of BI’s stroke drug Aggrenox off the market until at least July 2015.